Format

Send to

Choose Destination
ERJ Open Res. 2019 Jul 29;5(3). pii: 00100-2019. doi: 10.1183/23120541.00100-2019. eCollection 2019 Jul.

Evaluation of inter-observer variation for computed tomography identification of childhood interstitial lung disease.

Author information

1
Dept of Respiratory Medicine, University College London, London, UK.
2
Centre for Medical Image Computing, University College London, London, UK.
3
Dept of Radiology, Great Ormond Street Hospital, London, UK.
4
Dept of Radiology, University of Cincinnati College of Medicine, and Cincinnati Children's Hospital, Cincinnati, OH, USA.
5
Dept of Radiology, Royal Brompton and Harefield NHS Foundation Trust, London, UK.
6
Dept of Pediatric Radiology, University Hospital Vall d'Hebron, Barcelona, Spain.
7
Dept of Radiology, Ospedale Pediatrico Bambino Gesù, Rome, Italy.
8
Dept of Radiology, Royal Free London NHS Foundation Trust, London, UK.
9
Dept of Paediatric Respiratory Medicine, University Hospital Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain; CIBERER, Spain.
10
Dept of Paediatric Respiratory Medicine, Great Ormond Street Hospital, London, UK.
11
Dept of Hisopathology, Royal Brompton and Harefield NHS Foundation Trust and National Heart and Lung Institute, Imperial College, London, UK.
12
Dept of Pediatrics, Division of Pediatric Pulmonology, University of North Carolina-Chapel Hill, Chapel Hill, NC, USA.
13
Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK.
14
Interstitial Lung Disease Unit, Royal Brompton and Harefield NHS Foundation Trust, London, UK.
15
Depts of Paediatrics and Paediatric Respiratory Medicine, Imperial College and Royal Brompton Hospital, London, UK.

Abstract

Making chILD diagnoses on CT is poorly reproducible, even amongst sub-specialists. CT might best improve diagnostic confidence in a multidisciplinary team setting when augmented with clinical, functional and haematological results. http://bit.ly/327jRCw.

Conflict of interest statement

Conflict of interest: J. Jacob reports personal fees from Boehringer Ingelheim (advisory board fees) and Roche, outside the submitted work. Conflict of interest: C.M. Owens reports personal fees from Boehringer Ingelheim, outside the submitted work. Conflict of interest: A.S. Brody reports personal fees from Vertex, outside the submitted work. Conflict of interest: T. Semple reports personal fees from Vertex, outside the submitted work. Conflict of interest: T.A. Watson has nothing to disclose. Conflict of interest: A. Calder has nothing to disclose. Conflict of interest: P. Garcia-Peña has nothing to disclose. Conflict of interest: P. Toma has nothing to disclose. Conflict of interest: A. Devaraj reports personal fees from Boehringer Ingelheim, Roche, and GSK, outside the submitted work. Conflict of interest: H. Walton has nothing to disclose. Conflict of interest: A. Moreno-Galdó reports personal fees from Abbvie, Actelion, and Novartis, outside the submitted work. Conflict of interest: P. Aurora has nothing to disclose. Conflict of interest: A. Rice reports personal fees from AbbVie, outside the submitted work. Conflict of interest: T.J. Vece has nothing to disclose. Conflict of interest: S. Cunningham reports personal fees from Boehringer Ingelheim, outside the submitted work. Conflict of interest: A. Altmann has nothing to disclose. Conflict of interest: A.U. Wells reports personal fees from Intermune (advisory board and speaker fees), Boehringer Inlgeheim (advisory board and speaker fees), Gilead (advisory board fees), MSD (advisory board fees), Roche (advisory board and speaker fees), Bayer (advisory board and speaker fees), and Chiesi (speaker fees), outside the submitted work. Conflict of interest: A.G. Nicholson reports personal fees from Boehringer Ingelheim (advisory board fees), Roche, Medical Quantitative Image analysis, and Galapagos, outside the submitted work. Conflict of interest: A. Bush has nothing to disclose.

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center